Comparison of apixaban 5 mg vs 2.5 mg for the prevention of cancer-associated venous thromboembolism: A pooled analysis of two studies
21 June 2025 (08:00 - 18:00)
Organised by: 
Abstract
Slides
About the speaker
Lakeland Regional Medical Centre, Lakeland (United States of America)
59 More presentations in this session
Doctor M. Canavera Ibanez (Bogota, CO)
Doctor B. Andrade (Santarem, PT)
Doctor B. Aumente Rodriguez (Salamanca, ES)
Access the full session
The Event
ESC Cardio-Oncology 2025
21 June 2025
08:00 CET
You may be interested in
Congress Presentation
